Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients: A pooled analysis.

Muro S, Yoshisue H, Kostikas K, Olsson P, Gupta P, Wedzicha JA.

Respirology. 2019 Jul 24. doi: 10.1111/resp.13651. [Epub ahead of print]

2.

Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives.

Rhee CK, Yoshisue H, Lad R.

Adv Ther. 2019 Mar;36(3):495-519. doi: 10.1007/s12325-019-0893-3. Epub 2019 Feb 11. Review.

PMID:
30742242
3.

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.

Igarashi A, Fukuchi Y, Hirata K, Ichinose M, Nagai A, Nishimura M, Yoshisue H, Ohara K, Gruenberger JB.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2629-2641. doi: 10.2147/COPD.S167476. eCollection 2018.

4.

Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.

Adachi M, Kozawa M, Yoshisue H, Lee Milligan K, Nagasaki M, Sasajima T, Miyamoto T, Ohta K.

Respir Med. 2018 Aug;141:56-63. doi: 10.1016/j.rmed.2018.06.021. Epub 2018 Jun 28.

PMID:
30053973
5.

Discovery and Characterization of Allosteric WNK Kinase Inhibitors.

Yamada K, Zhang JH, Xie X, Reinhardt J, Xie AQ, LaSala D, Kohls D, Yowe D, Burdick D, Yoshisue H, Wakai H, Schmidt I, Gunawan J, Yasoshima K, Yue QK, Kato M, Mogi M, Idamakanti N, Kreder N, Drueckes P, Pandey P, Kawanami T, Huang W, Yagi YI, Deng Z, Park HM.

ACS Chem Biol. 2016 Dec 16;11(12):3338-3346. Epub 2016 Oct 19.

PMID:
27712055
6.

[New therapeutic choice for COPD: glycopyrronium bromide, a long-acting muscarinic antagonist].

Yoshisue H, Kozawa M, Hiratsuka M, Nakanishi M.

Nihon Yakurigaku Zasshi. 2013 Oct;142(4):190-9. Review. Japanese. No abstract available.

PMID:
24107524
7.

Chronological expression of Ciliated Bronchial Epithelium 1 during pulmonary development.

Haitchi HM, Yoshisue H, Ribbene A, Wilson SJ, Holloway JW, Bucchieri F, Hanley NA, Wilson DI, Zummo G, Holgate ST, Davies DE.

Eur Respir J. 2009 May;33(5):1095-104. doi: 10.1183/09031936.00157108. Epub 2009 Feb 12.

8.

Cellular localization of interleukin 13 receptor alpha2 in human primary bronchial epithelial cells and fibroblasts.

Konstantinidis AK, Puddicombe SM, Mochizuki A, Sheth PD, Yang IA, Yoshisue H, Wilson SJ, Davies DE, Holgate ST, Holloway JW.

J Investig Allergol Clin Immunol. 2008;18(3):174-80.

9.

The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma.

Puxeddu I, Pang YY, Harvey A, Haitchi HM, Nicholas B, Yoshisue H, Ribatti D, Clough G, Powell RM, Murphy G, Hanley NA, Wilson DI, Howarth PH, Holgate ST, Davies DE.

J Allergy Clin Immunol. 2008 Jun;121(6):1400-6, 1406.e1-4. doi: 10.1016/j.jaci.2008.03.003. Epub 2008 Apr 14.

PMID:
18410963
10.

Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts.

Yoshisue H, Kirkham-Brown J, Healy E, Holgate ST, Sampson AP, Davies DE.

J Allergy Clin Immunol. 2007 Jan;119(1):132-40. Epub 2006 Nov 7.

PMID:
17208594
11.

The genetics of asthma: ADAM33 as an example of a susceptibility gene.

Holgate ST, Yang Y, Haitchi HM, Powell RM, Holloway JW, Yoshisue H, Pang YY, Cakebread J, Davies DE.

Proc Am Thorac Soc. 2006 Jul;3(5):440-3. Review.

PMID:
16799089
12.

Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells.

Yoshisue H, Hasegawa K.

Biosci Biotechnol Biochem. 2004 Oct;68(10):2024-31.

13.

Characterization of ciliated bronchial epithelium 1, a ciliated cell-associated gene induced during mucociliary differentiation.

Yoshisue H, Puddicombe SM, Wilson SJ, Haitchi HM, Powell RM, Wilson DI, Pandit A, Berger AE, Davies DE, Holgate ST, Holloway JW.

Am J Respir Cell Mol Biol. 2004 Nov;31(5):491-500. Epub 2004 Jul 8.

PMID:
15242845
14.

Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library.

Yoshisue H, Suzuki K, Kawabata A, Ohya T, Zhao H, Sakurada K, Taba Y, Sasaguri T, Sakai N, Yamashita S, Matsuzawa Y, Nojima H.

Atherosclerosis. 2002 Jun;162(2):323-34.

PMID:
11996952
15.

A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.

Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, Takeda T, Imabeppu S, Kato Y, Hanai N, Anazawa H, Kuga T, Nishi T.

J Immunol. 1999 Aug 1;163(3):1602-10.

16.
17.
18.

Cloning and characterization of a Bacillus thuringiensis homolog of the spoIIID gene from Bacillus subtilis.

Yoshisue H, Ihara K, Nishimoto T, Sakai H, Komano T.

Gene. 1995 Feb 27;154(1):23-9.

PMID:
7867944
20.
21.

Transcriptional regulation of Bacillus thuringiensis subsp. israelensis mosquito larvicidal crystal protein gene cryIVA.

Yoshisue H, Fukada T, Yoshida K, Sen K, Kurosawa S, Sakai H, Komano T.

J Bacteriol. 1993 May;175(9):2750-3.

22.

Effects of Bacillus thuringiensis var. israelensis 20-kDa protein on production of the Bti 130-kDa crystal protein in Escherichia coli.

Yoshisue H, Yoshida K, Sen K, Sakai H, Komano T.

Biosci Biotechnol Biochem. 1992 Sep;56(9):1429-33.

Supplemental Content

Loading ...
Support Center